Literature DB >> 20673238

Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major.

Katharina A Remer1, Bianca Roeger, Christine Hambrecht, Heidrun Moll.   

Abstract

Dendritic cell (DC)-mediated vaccination against Leishmania major induces a parasite-specific T helper 1 (Th1) response and long-lasting protective immunity in susceptible mice. As the cytokine interleukin-12 required for induction of this Th1 response is not derived from the transferred DC, but has to be produced by the vaccinated host, we examined cross-presentation of transferred DC via resident DC of the host and cross-activation with natural killer (NK) cells as mechanisms supporting the induction of protective immunity after DC-mediated vaccination. Co-culture with DC that had been conditioned ex vivo by loading with L. major lysate and stimulation with CpG-containing oligodeoxynucleotides did not result in the activation of naive DC in vitro. Furthermore, L. major antigen from conditioned DC was not cross-presented to a significant extent in vivo. In contrast, co-culture of DC with NK cells led to cross-activation of both cell populations with induction of interferon-γ, which was dependent on the activation status of the conditioned DC. Transient depletion of NK cells during vaccination of L. major-susceptible mice with conditioned DC resulted in reduced protection. Our findings indicate that cross-presentation of conditioned DC after DC-based vaccination against L. major plays a minor role in the induction of protective immunity. However, we demonstrated for the first time that the capacity of DC to mediate protection against L. major is supported by cross-activation with NK cells of the host and NK-cell-derived interferon-γ.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673238      PMCID: PMC2999807          DOI: 10.1111/j.1365-2567.2010.03329.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.

Authors:  Patricia Byrne; Peter McGuirk; Stephen Todryk; Kingston H G Mills
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

Review 2.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

3.  A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies.

Authors:  Y Zhi-Jun; N Sriranganathan; T Vaught; S K Arastu; S A Ahmed
Journal:  J Immunol Methods       Date:  1997-12-15       Impact factor: 2.303

Review 4.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

5.  Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major.

Authors:  Johannes K Schnitzer; Simon Berzel; Marcela Fajardo-Moser; Katharina A Remer; Heidrun Moll
Journal:  Vaccine       Date:  2010-07-06       Impact factor: 3.641

6.  Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.

Authors:  Ingeborg Becker; Norma Salaiza; Magdalena Aguirre; José Delgado; Nuria Carrillo-Carrasco; Laila Gutiérrez Kobeh; Adriana Ruiz; Rocely Cervantes; Armando Pérez Torres; Nallely Cabrera; Augusto González; Carmen Maldonado; Armando Isibasi
Journal:  Mol Biochem Parasitol       Date:  2003-08-31       Impact factor: 1.759

7.  Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

Authors:  José R Ramírez-Pineda; Anja Fröhlich; Christof Berberich; Heidrun Moll
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  Natural killer (NK) cells play a critical role in the early innate immune response to Chlamydophila abortus infection in mice.

Authors:  A J Buendía; C M Martínez; N Ortega; L Del Río; M R Caro; M C Gallego; J Sánchez; J A Navarro; F Cuello; J Salinas
Journal:  J Comp Pathol       Date:  2004-01       Impact factor: 1.311

9.  Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

Authors:  Robbie B Mailliard; Young-Ik Son; Richard Redlinger; Patrick T Coates; Adam Giermasz; Penelope A Morel; Walter J Storkus; Pawel Kalinski
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.426

10.  Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.

Authors:  L Carrera; R T Gazzinelli; R Badolato; S Hieny; W Muller; R Kuhn; D L Sacks
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  4 in total

1.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Ageing dangerously; homing of senescent CD8 T cells in cutaneous Leishmaniasis.

Authors:  Simon Milling
Journal:  Immunology       Date:  2020-04       Impact factor: 7.397

Review 3.  Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.

Authors:  Daniel Feijó; Rafael Tibúrcio; Mariana Ampuero; Cláudia Brodskyn; Natalia Tavares
Journal:  J Immunol Res       Date:  2016-01-19       Impact factor: 4.818

Review 4.  Natural killer cells in experimental and human leishmaniasis.

Authors:  Christian Bogdan
Journal:  Front Cell Infect Microbiol       Date:  2012-05-29       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.